Everest Medicines Issues April 2026 Reminder on Electronic Dissemination of Corporate Communications

Bulletin Express04-23

Everest Medicines Limited has released a reminder dated 24 April 2026 reaffirming its shift to fully electronic dissemination of corporate communications.

The company first announced the arrangement on 6 September 2024. Under Hong Kong Stock Exchange Listing Rule 2.07A, actionable corporate communications—including annual reports, interim reports, circulars, meeting notices and proxy forms—will be distributed by email once shareholders provide a functional address. Both English and Chinese versions of every document will be posted on the company’s website (www.everestmedicines.com) and HKEx’s website (www.hkexnews.hk); printed copies will no longer be sent automatically.

Shareholders who have not yet supplied an email address are urged to: 1. Scan the personalized QR code on the enclosed reply form to register an email address; or 2. Return the signed reply form to the Hong Kong Share Registrar, Computershare Hong Kong Investor Services Limited.

If no valid email address is received, future actionable corporate communications will be mailed in hard copy until an email is registered. Shareholders may also opt to receive printed documents for one year by emailing everestmedicines.ecom@computershare.com.hk and providing name, address and the print request.

Everest Medicines underscores the importance of accurate contact information to avoid delays in receiving shareholder materials. Queries can be directed to the registrar at everestmedicines.ecom@computershare.com.hk.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/1180840684?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-04-23 22:46","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1180840684","market":"us","top_or_hot":-1,"title":"Everest Medicines Issues April 2026 Reminder on Electronic Dissemination of Corporate Communications","media":"Bulletin Express","content":"<p>Everest Medicines Limited has released a reminder dated 24 April 2026 reaffirming its shift to fully electronic dissemination of corporate communications.</p>\n<p>The company first announced the arrangement on 6 September 2024. Under Hong Kong Stock Exchange Listing Rule 2.07A, actionable corporate communications—including annual reports, interim reports, circulars, meeting notices and proxy forms—will be distributed by email once shareholders provide a functional address. Both English and Chinese versions of every document will be posted on the company’s website (www.everestmedicines.com) and HKEx’s website (www.hkexnews.hk); printed copies will no longer be sent automatically.</p>\n<p>Shareholders who have not yet supplied an email address are urged to:\n1. Scan the personalized QR code on the enclosed reply form to register an email address; or  \n2. Return the signed reply form to the Hong Kong Share Registrar, Computershare Hong Kong Investor Services Limited.</p>\n<p>If no valid email address is received, future actionable corporate communications will be mailed in hard copy until an email is registered. Shareholders may also opt to receive printed documents for one year by emailing everestmedicines.ecom@computershare.com.hk and providing name, address and the print request.</p>\n<p>Everest Medicines underscores the importance of accurate contact information to avoid delays in receiving shareholder materials. Queries can be directed to the registrar at everestmedicines.ecom@computershare.com.hk.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Everest Medicines Issues April 2026 Reminder on Electronic Dissemination of Corporate Communications</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nEverest Medicines Issues April 2026 Reminder on Electronic Dissemination of Corporate Communications\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1053168898\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Bulletin Express </p>\n<p class=\"h-time\">2026-04-23 22:46</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Everest Medicines Limited has released a reminder dated 24 April 2026 reaffirming its shift to fully electronic dissemination of corporate communications.</p>\n<p>The company first announced the arrangement on 6 September 2024. Under Hong Kong Stock Exchange Listing Rule 2.07A, actionable corporate communications—including annual reports, interim reports, circulars, meeting notices and proxy forms—will be distributed by email once shareholders provide a functional address. Both English and Chinese versions of every document will be posted on the company’s website (www.everestmedicines.com) and HKEx’s website (www.hkexnews.hk); printed copies will no longer be sent automatically.</p>\n<p>Shareholders who have not yet supplied an email address are urged to:\n1. Scan the personalized QR code on the enclosed reply form to register an email address; or  \n2. Return the signed reply form to the Hong Kong Share Registrar, Computershare Hong Kong Investor Services Limited.</p>\n<p>If no valid email address is received, future actionable corporate communications will be mailed in hard copy until an email is registered. Shareholders may also opt to receive printed documents for one year by emailing everestmedicines.ecom@computershare.com.hk and providing name, address and the print request.</p>\n<p>Everest Medicines underscores the importance of accurate contact information to avoid delays in receiving shareholder materials. Queries can be directed to the registrar at everestmedicines.ecom@computershare.com.hk.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"01952","symbol_name":"云顶新耀","start_time":0,"source_url":"","article_id":"1180840684","we_media_id":"1053168898","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1180840684","pubTimestamp":1776955610,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Bulletin Express","introduction":"Full Coverage of HK & US Stock Announcements","home_visible":1,"id":"1053168898","head_image":"https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e"},"summary":"Everest Medicines Limited has released a reminder dated 24 April 2026 reaffirming its shift to fully electronic dissemination of corporate communications. The company first announced the arrangement...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"01952":"云顶新耀"},"translate_title":"Everest Medicines发布2026年4月公司通讯电子传播提醒","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"01952":1},"content_text":"Everest Medicines Limited has released a reminder dated 24 April 2026 reaffirming its shift to fully electronic dissemination of corporate communications.\nThe company first announced the arrangement on 6 September 2024. Under Hong Kong Stock Exchange Listing Rule 2.07A, actionable corporate communications—including annual reports, interim reports, circulars, meeting notices and proxy forms—will be distributed by email once shareholders provide a functional address. Both English and Chinese versions of every document will be posted on the company’s website (www.everestmedicines.com) and HKEx’s website (www.hkexnews.hk); printed copies will no longer be sent automatically.\nShareholders who have not yet supplied an email address are urged to:\n1. Scan the personalized QR code on the enclosed reply form to register an email address; or  \n2. Return the signed reply form to the Hong Kong Share Registrar, Computershare Hong Kong Investor Services Limited.\nIf no valid email address is received, future actionable corporate communications will be mailed in hard copy until an email is registered. Shareholders may also opt to receive printed documents for one year by emailing everestmedicines.ecom@computershare.com.hk and providing name, address and the print request.\nEverest Medicines underscores the importance of accurate contact information to avoid delays in receiving shareholder materials. Queries can be directed to the registrar at everestmedicines.ecom@computershare.com.hk.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"SGX","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.42.0","shortVersion":"4.42.0","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1180840684","isCrawlerRequest":true}